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Objectives: This review assessed current practice in the preparation of rapid reviews by
health technology assessment (HTA) organizations, both internationally and in the
Australian context, and evaluated the available peer-reviewed literature pertaining to the
methodology used in the preparation of these reviews.
Methods: A survey tool was developed and distributed to a total of fifty International
Network of Agencies for Health Technology Assessment (INAHTA) members and other
selected HTA organizations. Data on a broad range of themes related to the conduct of
rapid reviews were collated, discussed narratively, and subjected to simple statistical
analysis where appropriate. Systematic searches of the Cochrane Library, EMBASE,
MEDLINE, and the Australian Medical Index were undertaken in March 2007 to identify
literature pertaining to rapid review methodology. Comparative studies, guidelines,
program evaluations, methods studies, commentaries, and surveys were considered for
inclusion.
Results: Twenty-three surveys were returned (46 percent), with eighteen agencies
reporting on thirty-six rapid review products. Axiomatic trends were identified, but there
was little cohesion between organizations regarding the contents, methods, and definition
of a rapid review. The twelve studies identified by the systematic literature search did not
The authors acknowledge Dr. Ann Scott for her assistance in the preparation of this review. We are also indebted to all agencies and individuals who
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specifically address the methodology underpinning rapid review; rather, many highlighted
the complexity of the area. Authors suggested restricted research questions and
truncated search strategies as methods to limit the time taken to complete a review.
Conclusions: Rather than developing a formalized methodology by which to conduct
rapid reviews, agencies should work toward increasing the transparency of the methods
used for each review. It is perhaps the appropriate use, not the appropriate methodology,
of a rapid review that requires future consideration.
Keywords: Review, Health technology assessment, Methods
With the current proliferation of healthcare technologies, it
is a continued reality of the health technology assessment
(HTA) environment that advice on health technologies will
be required quickly by decision makers. This can conflict
with the requirements of traditional HTAs, which may re-
quire substantial lengths of time to gather, analyze, interpret,
review, and publish findings. This can create a tension be-
tween the demands of HTA and the imperatives of the policy-
making process, where HTA input must be timely if it is to
influence decisions (7).
Thus, the use of “rapid review” is increasing, driven pri-
marily by this need to engage with policy makers, healthcare
professionals, and consumers in a timely manner to pro-
vide evidence-based recommendations pertaining to health-
care activities and decisions. However, while this concept of
rapid review has been prominent in the discourse surround-
ing HTA for some time, the HTA community is yet to reach
a consensus regarding their validity and the most appropriate
methodology to use in their preparation.
Within the context of a broader assessment of current
methods and practice in HTA, the Australian Safety and Ef-
ficacy Register of New Interventional Procedures – Surgical
(ASERNIP-S) has evaluated several aspects relating to the
preparation of rapid reviews. Through the use of a survey
tool and extensive Internet searching, current practice in the
preparation of rapid reviews was assessed. This strategy was
complemented by a systematic literature search designed to
identify and examine the current evidence base pertaining
to rapid review methodology. The assessment also incorpo-
rated a comparative element, examining the differences in
essential conclusions between rapid and full reviews of the
same topic; the results of this comparison are the focus of
an independent article. The purpose of the review was to
draw together data from multiple sources to inform debate,
strengthen methodological development, and open interna-
tional dialogue between agencies regarding this area of health
technology assessment.
METHODS
Survey of HTA Organizations
Building upon an INAHTA survey undertaken in 2006, a
new survey tool was developed and distributed to all In-
ternational Network of Agencies for Health Technology
Assessment (INAHTA) members (forty-six Agencies, see
www.inahta.org/) in March 2007. Four other HTA agencies
that are not members of INAHTA were also contacted due
to their prominence in the field: National Institute for Clin-
ical Excellence (NICE; United Kingdom); Malaysian HTA
Program; Singapore Health Authority; and Agostino Gemelli
University Teaching Hospital (Italy).
The survey was developed in consultation with an
international panel of HTA experts and addressed a broad
range of themes relating to the conduct of rapid reviews.
Using both open-ended narrative and specific categorical
questions, respondents were asked about the administration
of the rapid review process, research strategies, composition
of rapid review products, and the use of peer review and ex-
ternal experts in the process. Respondents were also asked to
compare several features of their rapid review products with
those of full reviews. For the purposes of this report, rapid
review was defined as “any HTA report or systematic review
that has taken between 1 and 6 months to produce which con-
tains the elements of a comprehensive literature search.” The
survey is available as an appendix to the full review written
by ASERNIP-S on this topic in July 2007, from http://www.
surgeons.org/Content/NavigationMenu/Research/ASERNI-
PS/ASERNIPSPublications/Other_Reports1.htm.
The survey was distributed electronically by means of
the INAHTA Secretariat, with reminder emails sent after
1 month. If a response was not received, further follow-up
was undertaken.
Response data were collated by means of spreadsheet
tabulation. The main outcomes were discussed narratively.
Simple descriptive statistics were limited to the calculation
of percentage values across the data set.
Identification of Literature on Rapid
Review Methodology
A systematic search was conducted of MEDLINE (1950–
March 2007), EMBASE (1980–March 2007), Australasian
Medical Index (2004–March 2007), and the Cochrane
Database of Methodology Reviews and Methodology Reg-
ister (Issue 4, 2006). Search terms used in The Cochrane
Library were: methodology AND (rapid OR accelerated OR
quality assessment). More complex algorithms used in MED-
LINE, EMBASE, and AMI are detailed in Table 1. The In-
ternational Journal of Technology Assessment in Healthcare
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Table 1. Search Algorithms










3 1 OR 2 1 OR 2
4 KW: rapid KW: rapid
5 KW: methodology KW: methodology
6 KW: accelerated KW: accelerated
7 KW: quality assessment KW: quality assessment
8 KW: accuracy KW: accuracy
9 KW: quality KW: quality
10 KW: speed KW: speed
11 4 OR 5 OR 6 OR 7 OR 8
OR 9 OR 10
4 OR 5 OR 6 OR 7 OR 8 OR 9
OR 10
12 3 AND 11 3 AND 11
∗Subject heading.
KW, keyword.
(1998–March 2007) was also hand-searched for germane ar-
ticles, which were retrieved as appropriate.
Inclusion Criteria. Articles were selected for inclu-
sion if the abstract contained information on any one of sev-
eral outcomes reported in either a qualitative or quantitative
manner, including rapid review initiation and rationale, rapid
review methodology, content/completion of the rapid review,
and quality evaluation of the rapid review.
Comparative studies, guidelines, program evaluations,
methods studies, commentaries, and surveys were all consid-
ered for inclusion. The bibliographies of all included studies
were manually searched for relevant references that may have
been missed in the database search (pearling). Searches were
initially conducted without language restriction; however,
foreign language articles were subsequently excluded on a
case-by-case basis due to time and financial constraints.
RESULTS
Survey of HTA Organizations
Products, Rationale, and Commissioning Bod-
ies. The twenty-three agencies who returned the survey col-
lectively described thirty-six rapid review products. Of these,
seventeen products took between 1 and 3 months to complete,
sixteen products took between 3 and 6 months to complete,
and three products did not fit into the designated categories
and have been detailed separately. These categories are con-
sidered in more detail in the full report; the following results
are generally composite. As respondents were able to tick
more than one response, percentages do not consistently to-
tal 100 percent.
Collectively, the most commonly stated reason for con-
ducting a rapid review was in response to political urgency
and/or to support decisions (44 percent). Limited time and
resources (33 percent) and to answer a question raised in a
previous HTA and/or to answer a specific question (31 per-
cent) were the next most frequent reasons given, followed
by clinical urgency and uptake of technology (17 percent for
both).
When examined collectively, many (69 percent) respon-
dents indicated that macro-decision makers, such as govern-
ments and health ministries, commissioned the rapid reports.
Organizations considered to be meso-decision makers, such
as hospitals and community health agencies, were the com-
missioners in nearly half (47 percent) of the cases, and micro-
decision makers (clinicians, patients, individual projects) in
39 percent.
Reflecting the commissioning bodies and frequent links
between HTA agencies and governments, the macro-level
decision makers were most often the intended audience for
rapid reviews (72 percent). This finding was followed by
micro-level audiences (58 percent) and meso-level audiences
(31 percent).
Research Strategies. Approximately half of the re-
spondents reported conducting a systematic search of many
databases to identify evidence for rapid reviews, while the
other half reported undertaking systematic searches of a re-
stricted number of databases. Gray literature searching was
reported by 42 percent of respondents, with hand-searching
used by only 25 percent. Axiomatically, the time line of the
review tended to indicate the level of literature searching
undertaken: for example, in the 1- to 3-month category, a
systematic search of many databases was reported by only
35 percent of responders, whereas in the 3- to 6-month cat-
egory, 75 percent of the respondents reported a systematic
search of many databases.
This finding contrasts with the research strategies used
in the full systematic reviews. Thirteen agencies responded
to the questions comparing rapid and full review products: all
thirteen agencies reported that a systematic search of many
databases was undertaken for the preparation of full sys-
tematic reviews, 69 percent conducted hand-searches and
77 percent examined gray literature.
The responses in relation to whether the rapid review
products excluded specific types of studies revealed that no
rapid review product excluded systematic reviews; 6 percent
excluded randomized controlled trials (RCTs); 17 percent ex-
cluded nonrandomized controlled trials; and 83 percent ex-
cluded case series. Thus, as the level of evidence of a study
decreased, it was more likely to be excluded. Seven agen-
cies indicated in the additional comments that the criteria
for excluding studies were dependent on the availability of
published data, and that lower levels of evidence would be
used if there was nothing else available. Responses indicated
that full reviews were less likely to exclude different study
types: no full review excluded RCTs, only 8 percent excluded
nonrandomized studies, and 31 percent excluded case series.
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Composition and Peer Review. Clinical outcomes
were included in nearly all of the rapid review products
(94 percent). Economic factors were considered by 78 per-
cent of the products, and 53 percent included social factors,
such as ethics. Almost three quarters of the products included
some form of quality assessment of the included evidence.
When compared with rapid reviews, full systematic reviews
were more likely to report clinical outcomes (100 percent)
and examine economic and social factors (92 percent and
85 percent, respectively).
In total, more than half of the respondents (67 per-
cent) reported the use of external experts during the prepara-
tion/evaluation of their rapid review products; of this group,
59 percent indicated that this lengthened the time the re-
port took to complete. Comparison to full systematic reviews
showed that reviews completed over a longer timeframe in-
corporated elements of peer review more commonly than
rapid reviews.
Literature on Rapid Review Methodology
There was a paucity of information identified in the liter-
ature regarding specific methodologies undertaken in rapid
reviews of health technologies. After evaluating 101 abstracts
arising from the literature search, a total of twelve relevant
studies were identified: one guideline abstract, three program
evaluations, two comparative studies, two methods studies,
three commentaries, and one survey.
Several authors acknowledged the complexities inherent
in conducting rapid reviews, suggesting that it is difficult to
accomplish the triad of responsiveness to short timeframes,
scientific rigor, and transparency in a manner consistently ac-
ceptable to all stakeholders (5). However, despite these chal-
lenges, some HTA organizations reported producing a con-
siderable number of rapid reviews. An overview of the Cana-
dian HTA products produced between 1995 and 2001 indi-
cated that 17 percent of the total HTA output were “short doc-
uments,” indicating the increasing importance placed upon
responsiveness to short timeframes (8). Furthermore, the in-
creased opportunity to contextualize rapid reviews within
specific healthcare settings is an acknowledged strength of
this style of product (7;9).
Other authors urged caution in the production of rapid as-
sessments, while acknowledging their potential influence on
policy making. Rapid review was proposed as an important
intermediary step in the assessment of emerging technolo-
gies, to be followed by a more comprehensive assessment
(12). Detailed HTAs, undertaken over months or even years,
would remain essential to address certain questions (6). A
comparative study exploring the differences in the complex-
ity and findings of rapid and full reviews evaluated the min-
imum information response required to accurately answer
a specific policy question (11; identified by means of per-
sonal communication). It was found that the extra clinical
information included in a full assessment may be extremely
valuable to clinicians, but is of less importance to policy or
other nonclinical decision makers, highlighting the need to
have a thorough understanding of the requirements of the
intended audience before undertaking a rapid review.
Methodological differences that may distinguish a rapid
review from a full HTA as discussed in published litera-
ture included the development of a limited research question
and truncated literature searching. Aidelsburger et al. (1)
proposed that a rapid HTA should focus on the study ques-
tion by exactly defining the technology, outcomes, and study
population to be examined, thereby facilitating an accurate
literature search and reducing the number of identified stud-
ies. Furthermore, in an examination of the use and impact of
rapid HTAs, it was stated that the rapid reviews under consid-
eration provided somewhat restricted advice, given that they
were generally confined to addressing questions of efficacy
or effectiveness (7). This contrasts with the broader research
questions commonly addressed by full HTAs, where issues
of efficacy/effectiveness are frequently considered in con-
junction with those of safety, economic viability, legality,
and ethics.
The potential impact that altering search methodology
may have on the validity of the review findings was assessed
by two groups. After examining the indexing characteristics
of a variety of clinical trials, Egger et al. (4) concluded that
“systematic reviews that are based on a search of English lan-
guage literature that is accessible in the major bibliographic
databases will often produce results that are close to those ob-
tained from reviews based on more comprehensive searches
that are free from language restrictions.” The Cochrane Con-
trolled Trials Register (CCTR) was found to be the single
best source of randomized controlled trial references, with
additional database searching retrieving only a small per-
centage of extra trials (10). Best et al. (2) also acknowledged
that exhaustive data collection may have little effect on the
final recommendation, although no empirical evidence was
provided to support this claim.
Only one study could be identified that evaluated the
validity and reliability of rapid reviews compared with more
extensive follow-up reports (3). In five of six cases, the con-
clusions reached by the rapid review product (“Technotes”)
was confirmed by later peer-reviewed reports. The only dis-
agreement in conclusions was a single Technote concluding
that an intervention was experimental, whereas a larger cost-
effectiveness study indicated the intervention to be reported
as safe and efficacious in the literature, although no reason
was provided for this discrepancy.
DISCUSSION
Survey of HTA Organizations
The responses gathered from the survey indicated that there
is currently no uniform description of what constitutes a rapid
review product, with respondents reporting a variety of time
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lines, report components, search strategies, and evaluation
methodologies among the range of rapid reviews produced.
It is clear that there are difficulties in categorizing products
as “rapid” or “full” simply based on the length of time taken
to complete reviews.
The current survey demonstrated that there is no stan-
dardized methodology applied to the preparation of rapid
reviews, although different trends were identified. Rapid re-
view products were less likely to use systematic searches
of many databases, conduct hand-searches, and use gray lit-
erature than full systematic reviews. These results are ax-
iomatic and most likely stem from time constraints faced
when preparing rapid reviews. As the duration of the review
extended (i.e., from 1 to 3 months to 3 to 6 months), a trend
for more rigorous search strategies emerged. The effect that
truncated searching may have on the final conclusions of
rapid reviews is still unclear, although it has been suggested
that exhaustive data collections may have little effect on the
final recommendation of a report (2).
Inclusion of different types of evidence in rapid reviews
appeared to be done subjectively and reflected the avail-
ability of evidence more than the methodology of the re-
view. Agencies indicated that higher level evidence is gener-
ally preferable but not always available. The idea that some
rapid reviews may be based solely on existing systematic
reviews, thus creating a rapid review of overviews rather
than of primary evidence also emerged. This finding may
indicate an important potential role for rapid reviews, al-
lowing full review findings to be used in a local health-
care context by adding local perspective or national costing
implications.
Rapid reviews were less likely to use external experts
and peer review than full systematic reviews. This could re-
sult in rapid reviews (particularly those produced in 1 to
3 months), receiving little scrutiny from methodological and
clinical experts. The impact of this on review quality is un-
known and merits investigation, as high level decisions may
be made based on these reviews.
Although the rapid reviews and full systematic reviews
of all agencies included in this study have been described as
two distinct groups, they are likely to constitute many dis-
crete review products, encompassing differences in search
strategies, composition, and included study types. The sur-
vey did not ask whether systematic reviews used quality
assessment or critical appraisal. Although these may both
be considered fundamental elements of a systematic review,
confirmation of their existence would have strengthened the
results. Full systematic reviews, like rapid reviews are not
homogenous, which emphasizes the importance of detail-
ing research methodologies for these reviews (as well as any
other type of review). In the case of rapid reviews, this should
be done to avoid making them appear more valid than they
are. Failure to do this could result in full systematic reviews
appearing redundant to those who do not understand the im-
portant differences between the two types of products. This
may result in decision makers choosing to commission rapid
reviews rather than full systematic reviews. This may not be
appropriate in some instances, particularly for complex in-
terventions that may need to be investigated in greater depth
by a full systematic review.
The use of different types of reviews in determining
and implementing policy decisions was only briefly touched
on by the survey. Each of the review styles were commis-
sioned by a variety of bodies, including private healthcare
funds, hospital administrators, clinicians, and governments,
although the survey did demonstrate that shorter rapid re-
views were most likely to be written as a result of political
urgency. Within the small data set considered, there was no
clear correlation between the commissioning group and the
use of the review findings in policy making. The impact of
reviews on policy seemed to be more closely related to the
intended audience or the commissioning body than the na-
ture of the review, but given the relatively small sample size,
definitive conclusions regarding the impact that rapid reviews
have on policy making cannot be drawn.
Due to the limited survey group, the results of this analy-
sis could not be grouped by country or type of healthcare sys-
tem. Exploring whether there are any links between health-
care systems and the use of rapid reviews for policy making
may provide interesting results and could contribute to re-
vealing the international impact of these products.
Literature on Rapid Review Methodology
Evaluation of the available peer-reviewed literature con-
firmed the impression created by the survey results, namely
that there is a lack of standardized, explicit methodology for
the undertaking of rapid reviews. It may be that these prod-
ucts defy the description of prescriptive a priori methodology
due to their flexible and adaptive nature, which allows them to
be targeted to particular audiences within specific healthcare
contexts. Hence, the development of explicit, standardized
methodology regarding these products may be counterpro-
ductive, as it would limit one of their key strengths, namely
their adaptiveness.
Proposed methods for conducting rapid reviews, such as
limited searching and development of highly refined research
questions are yet to be adequately validated in the literature.
Clearly, refining the research question could mean that review
findings are less able to be generalized to smaller patient
populations or certain comparator interventions.
Truncated literature search strategies may often lead to
uncertainty surrounding the conclusions of a review. Con-
versely, however, it has been suggested that extensive liter-
ature searching can actually introduce bias into an evidence
base rather than limiting it, as trials that are harder to locate
can be of lower quality (4). It may be that resources would
be more appropriately directed to thorough quality assess-
ments of evidence available in major databases, rather than
extensive searching.
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Given the inherent variability of the size and composition
of the evidence base between interventions, it may not be
possible to validate methodological strategies for conducting
rapid reviews and apply them to every subject. Rather, each
topic must be evaluated by thorough scoping, and appropriate
methodology defined. This may highlight a greater need for
a panel of expert advisors to ensure that the nuances of each
topic have been adequately considered.
POLICY IMPLICATIONS
This review has identified that the current rapid review prod-
ucts being produced by HTA agencies are not well-defined
and are highly variable in their methodology. However, it is
a reality of the HTA environment that there will continue
to be pressure to produce reviews that are both timely and
accurate to support the ever-increasing speed of the policy-
making process in this area.
It is, therefore, recommended that, rather than develop-
ing a formalized methodology by which to conduct rapid re-
views, which may be inappropriate and oversimplified, agen-
cies should work to increase the transparency of the methods
used for each review. It would, thus, be useful if HTA agen-
cies could clearly identify their HTA products, with respect
to the commissioning group and purpose of the review along
with some general details outlining the methodologies used
in their preparation. In addition, policy makers need to ap-
preciate that certain parts of a comprehensive review (such
as an independent and complete economic evaluation) may
not realistically be completed in a rapid timeframe. Further-
more, methods for incorporating the advice of expert panels
in a timely manner need to be developed to ensure that rapid
reviews ask the correct questions and reach appropriate con-
clusions at both clinical and policy levels.
A rapid review should be written in answer to specific
questions, rather than as a quick alternative to a compre-
hensive systematic review. In this manner, rapid reviews
could be used to inform specific policy decisions in a
timely manner without losing any of the important infor-
mation that may be expected from a comprehensive review.
It is perhaps the focus on appropriate use, along with suit-
able methodologies, of a rapid review that requires future
consideration.
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